| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/24/1993 | WO1993011755A1 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
| 06/24/1993 | WO1993011668A1 Methods and compositions for reducing multi-drug resistance |
| 06/24/1993 | DE4142552A1 Monoklonale antikoerper gegen die typ i phospholipase a(pfeil abwaerts)2(pfeil abwaerts) als entzuendungshemmendes therapeutikum Monoclonal antibodies against type I phospholipase A (down arrow) 2 (down arrow) as therapeutic entzuendungshemmendes |
| 06/24/1993 | DE4142452A1 Mittel zur stimulierung der teilungsaktivitaet tierischer zellen Means for stimulation of teilungsaktivitaet animal cells |
| 06/24/1993 | CA2125980A1 A method for coating particles in a spray-drying plant |
| 06/24/1993 | CA2125966A1 Peptide nucleic acids and their effect on genetic material |
| 06/24/1993 | CA2125494A1 Composition and treatment with biologically active peptides and chelating agents |
| 06/24/1993 | CA2125400A1 Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation |
| 06/24/1993 | CA2125396A1 Reactive neutralizing human anti-gp 120 recombinant antibody, dna coding the same and use thereof |
| 06/24/1993 | CA2125279A1 Methods and compositions for reducing multi-drug resistance |
| 06/24/1993 | CA2125192A1 A process for generating a structural and functional diversity in a peptide sequence |
| 06/24/1993 | CA2125181A1 Trophoblast interferons and their use |
| 06/24/1993 | CA2124672A1 Cytokines with an upaired cysteine residue and conjugates thereof |
| 06/23/1993 | EP0548024A2 Aminosulphonic acid derivatives and process for their preparation |
| 06/23/1993 | EP0547932A1 Process for preparing an activated factor VII concentrate having a high purity |
| 06/23/1993 | EP0547699A1 Peptidyl derivatives as inhibitors of interleukin-1B converting enzyme |
| 06/23/1993 | EP0547484A1 Process for producing antibiotic R106-I |
| 06/23/1993 | EP0547317A1 Endothelin antagonists |
| 06/23/1993 | EP0547234A1 Remedy for osteoporosis |
| 06/23/1993 | EP0547229A1 External preparation containing cyclosporin |
| 06/23/1993 | EP0547223A1 Remedy for corneal damages |
| 06/23/1993 | EP0547203A1 In vivo delivery of active factors by co-cultured cell implants. |
| 06/23/1993 | EP0547180A1 Recombinant agents affecting thrombosis |
| 06/23/1993 | EP0547178A1 Novel cholecystokinin antagonists, their preparation and therapeutic use |
| 06/23/1993 | EP0547172A1 REGULATION OF T-CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
| 06/23/1993 | EP0547164A1 Methods for the diagnosis and treatment of diabetes |
| 06/23/1993 | EP0547163A1 Protein polyligands joined to a stable protein core |
| 06/23/1993 | EP0547140A1 Immunosuppressant composition |
| 06/23/1993 | EP0547137A1 Homoconjugated immunoglobulins |
| 06/23/1993 | EP0547099A1 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa. |
| 06/23/1993 | EP0547076A1 Cd58-specific monoclonal antibodies and their use |
| 06/23/1993 | EP0272278B1 $i(D)-GL CONJUGATE THERAPY |
| 06/23/1993 | EP0263172B1 Protein analogues of tissue plasminogen activator |
| 06/23/1993 | EP0249635B1 Word recognition in a speech recognition system using data reduced word templates |
| 06/23/1993 | EP0236330B1 Dna sequence encoding a hirudin-like protein and process for preparing such protein |
| 06/23/1993 | CN1073447A Kedarcidin antitumor chromophore |
| 06/22/1993 | US5221789 Interferon-gamma receptor fragment and its production |
| 06/22/1993 | US5221752 α-keto amide derivatives |
| 06/22/1993 | US5221740 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 06/22/1993 | US5221734 Separation by chromatography |
| 06/22/1993 | US5221732 Peptide antibiotic |
| 06/22/1993 | US5221683 Diaminopyridine compounds and methods of use |
| 06/22/1993 | US5221670 Rapamycin esters |
| 06/22/1993 | US5221668 Partially digested protein and L-arginine |
| 06/22/1993 | US5221667 Treating hypertension, hyperaldosteronism, congestive heart failure |
| 06/22/1993 | US5221665 Prevent hydrolysis of elastin |
| 06/22/1993 | US5221664 Inhibiting growth of a target cell or virus |
| 06/22/1993 | US5221620 Cloning and expression of transforming growth factor β2 |
| 06/22/1993 | US5221537 Tissue irrigating solutions |
| 06/21/1993 | CA2085782A1 Polyaspartamide derivatives as adsorbents for bile acids, polyaspartamide derivatives loaded with bile acids and process for their preparation and their use as pharmaceuticals |
| 06/20/1993 | CA2085715A1 Aminosulfonic acid derivatives and processes for their preparation |
| 06/20/1993 | CA2085300A1 Peptidyl derivatives as inhibitors of interleukin-1beta converting enzy eme |
| 06/19/1993 | WO1994004568A1 Peptide inhibitors of inflammation mediated by selectins |
| 06/19/1993 | CA2104099A1 Peptide inhibitors of inflammation mediated by selectins |
| 06/19/1993 | CA2059611A1 L-phenylalanyl-trna synthetase mutants, a process for the preparation thereof and the use thereof for the in vivo incorporation of non-proteinogenous amino acids into peptides or proteins |
| 06/18/1993 | EP0597845A4 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2. |
| 06/17/1993 | DE4140195A1 Stable nano-sol of sparingly water soluble pharmaceutical - has external phase of gelatin selected to balance charge on drug particle to improve bioavailability |
| 06/16/1993 | EP0547029A1 Immunogen and its use for preparing antibodies to HbA1c |
| 06/16/1993 | EP0547026A1 Gene coding for human colony-stimulating factors |
| 06/16/1993 | EP0547000A1 Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor compound |
| 06/16/1993 | EP0546951A1 Combination of liposome encapsulated antineoplastic agents, such as doxorubicin with colony stimulating factors |
| 06/16/1993 | EP0546870A1 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression |
| 06/16/1993 | EP0546813A2 Proteins for inhibiting adhesion of platelets to collagen |
| 06/16/1993 | EP0546533A2 Medical use of kininogenase |
| 06/16/1993 | EP0546213A1 Biologically active polypeptide and antibacterial agent |
| 06/16/1993 | EP0546156A1 Isolation and characterization of a novel protease from streptomyces lividans |
| 06/16/1993 | EP0546125A1 Osteogenic factor |
| 06/16/1993 | EP0546124A1 Multidomain hematopoiesis stimulators |
| 06/16/1993 | EP0546119A1 Cell density signal molecule isolated from embryonic tendon cells |
| 06/16/1993 | EP0546115A1 Peptides containing amino-polyols as transition-state mimics |
| 06/16/1993 | EP0546110A1 New insulin-like growth factor binding protein igfbp-5 |
| 06/16/1993 | EP0546108A1 Pro-drugs for cck antagonists |
| 06/16/1993 | EP0546101A1 METHOD OF INTERFERING WITH FORMATION OF $g(a)-ANTICHYMOTRYPSIN-$g(b)-PROTEIN COMPLEX AND SYNTHETIC PEPTIDES FOR USE THEREIN |
| 06/16/1993 | EP0546096A1 Macrophage activating factor from vitamin d binding protein |
| 06/16/1993 | EP0546084A1 PROTEASES CAUSING ABNORMAL DEGRADATION OF AMYLOID $g(b)-PROTEIN PRECURSOR |
| 06/16/1993 | EP0546081A1 New insulin-like growth factor binding protein (igfbp-4) |
| 06/16/1993 | EP0546077A1 Cd18 peptide medicaments for the treatment of disease |
| 06/16/1993 | EP0546076A1 Use of anti-ICAM antibodies in the manufacture of a medicament FOR TREATING ENDOTOXIN SHOCK |
| 06/16/1993 | EP0546075A1 Method and product for eliminating undesirable side effects of eating vegetables such as onion or garlic |
| 06/16/1993 | EP0546074A1 Genetic material encoding igfbp-5 |
| 06/16/1993 | EP0546068A1 Bioactive egf peptides for promotion of tissue regeneration and cancer therapy |
| 06/16/1993 | EP0546054A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 06/16/1993 | EP0546053A1 Genetic material encoding igfbp-4 |
| 06/16/1993 | EP0546013A1 Glucagon analogs with asp-9 replacements or deletions |
| 06/16/1993 | EP0546007A1 Product and use of it for the treatment of catabolic states comprising authentic igf-1 and hypocaloric amount of nutritients. |
| 06/16/1993 | EP0545991A1 Peptides that block human immunodeficiency virus infections and methods of use thereof |
| 06/16/1993 | EP0545972A1 Therapeutically active mixture of glutathion and anthocyan compounds. |
| 06/16/1993 | EP0545946A1 Growth-promoting agent |
| 06/16/1993 | EP0391974B1 Process for the purification of vitamin k-dependent blood clotting factors |
| 06/16/1993 | EP0308500B1 Human somatomedin carrier protein subunits and process for producing them |
| 06/16/1993 | CN1073264A Therapeutic and diagnostic methods based on tissue-specific NT-3 expression and receptor binding |
| 06/15/1993 | US5220013 Use of materials related to amyloid protein deposits |
| 06/15/1993 | US5220006 Identification of a suppressor of atherogenic apolipoprotein |
| 06/15/1993 | US5219999 Immunoglobulin g and process for the production thereof |
| 06/15/1993 | US5219998 Yeast-derived epidermal growth factor |
| 06/15/1993 | US5219995 Activating Factor II to Factor IIa using Factor Va and Factor Xa, wherein Factors II, Va, and Xa are all derived from a single impure protein fraction |
| 06/15/1993 | US5219994 Anticoagulant glycoprotein |
| 06/15/1993 | US5219993 Method of recovering purified epi protein from a solution especially a fermentation solution |
| 06/15/1993 | US5219991 Macrophage stimulating protein |
| 06/15/1993 | US5219990 Papillomavirus e2 trans-activation repressors |